Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

288 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prediction of radiographic progression during a treat-to-target strategy by the sequential application of MRI-proven bone marrow oedema and power-Doppler grade ≥2 articular synovitis in rheumatoid arthritis: Retrospective observational study.
Takatani A, Tamai M, Ohki N, Okamoto M, Endo Y, Tsuji S, Shimizu T, Umeda M, Fukui S, Sumiyoshi R, Nishino A, Koga T, Kawashiri SY, Iwamoto N, Igawa T, Ichinose K, Arima K, Nakamura H, Origuchi T, Uetani M, Kawakami A. Takatani A, et al. Among authors: origuchi t. Mod Rheumatol. 2023 Jul 4;33(4):708-714. doi: 10.1093/mr/roac077. Mod Rheumatol. 2023. PMID: 35856575
Modulation of the expression of membrane-bound CD54 (mCD54) and soluble form of CD54 (sCD54) in endothelial cells by glucosyl transferase inhibitor: possible role of ceramide for the shedding of mCD54.
Kawakami A, Hida A, Yamasaki S, Miyashita T, Nakashima K, Tanaka F, Ida H, Furuyama M, Migita K, Origuchi T, Eguchi K. Kawakami A, et al. Among authors: origuchi t. Biochem Biophys Res Commun. 2002 Aug 9;296(1):26-31. doi: 10.1016/s0006-291x(02)00829-x. Biochem Biophys Res Commun. 2002. PMID: 12147222
Clinical outcome and survival of secondary (AA) amyloidosis.
Tanaka F, Migita K, Honda S, Fukuda T, Mine M, Nakamura T, Yamasaki S, Ida H, Kawakami A, Origuchi T, Eguchi K. Tanaka F, et al. Among authors: origuchi t. Clin Exp Rheumatol. 2003 May-Jun;21(3):343-6. Clin Exp Rheumatol. 2003. PMID: 12846054
Akt is an endogenous inhibitor toward tumor necrosis factor-related apoptosis inducing ligand-mediated apoptosis in rheumatoid synovial cells.
Miyashita T, Kawakami A, Tamai M, Izumi Y, Mingguo H, Tanaka F, Abiru S, Nakashima K, Iwanaga N, Aratake K, Kamachi M, Arima K, Ida H, Migita K, Origuchi T, Tagashira S, Nishikaku F, Eguchi K. Miyashita T, et al. Among authors: origuchi t. Biochem Biophys Res Commun. 2003 Dec 12;312(2):397-404. doi: 10.1016/j.bbrc.2003.10.141. Biochem Biophys Res Commun. 2003. PMID: 14637151
Protection of mitochondrial perturbation by human T-lymphotropic virus type 1 tax through induction of Bcl-xL expression.
Nakashima K, Kawakami A, Hida A, Yamasaki S, Nakamura H, Kamachi M, Miyashita T, Tanaka F, Izumi Y, Tamai M, Ida H, Furuyama M, Koji T, Nakamura T, Migita K, Origuchi T, Eguchi K. Nakashima K, et al. Among authors: origuchi t. J Lab Clin Med. 2003 Nov;142(5):341-7. doi: 10.1016/S0022-2143(03)00134-3. J Lab Clin Med. 2003. PMID: 14647038
Osteoprotegerin (OPG) acts as an endogenous decoy receptor in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells.
Miyashita T, Kawakami A, Nakashima T, Yamasaki S, Tamai M, Tanaka F, Kamachi M, Ida H, Migita K, Origuchi T, Nakao K, Eguchi K. Miyashita T, et al. Among authors: origuchi t. Clin Exp Immunol. 2004 Aug;137(2):430-6. doi: 10.1111/j.1365-2249.2004.02534.x. Clin Exp Immunol. 2004. PMID: 15270863 Free PMC article.
288 results